Sodium butyrate induces ferroptosis in colorectal cancer cells by promoting NCOA4-FTH1-mediated ferritinophagy
International Immunopharmacology · 2025-10 · 163 · 115188
DOI: 10.1016/j.intimp.2025.115188 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2025-10. Verfasst von Lulin Liu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition and Food Hygiene, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical…. Hauptthemen laut MEDLINE: Nuclear Receptor Coactivators, Colorectal Neoplasms, Ferroptosis, Ferritins. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
Colorectal cancer (CRC) is a prevalent malignant tumor with limited therapeutic options, underscoring the need for novel and effective treatments. Ferroptosis, a form of programmed cell death associated with ferritinophagy and iron metabolism, presents a promising selective approach to inducing cancer cell death. Sodium butyrate (NaB), a metabolite derived from dietary fiber, has been shown to induce ferroptosis in CRC HCT-116 cells, though its underlying mechanism remains unclear. This study investigates whether NaB induces ferroptosis in CRC cells via ferritinophagy through the NCOA4-FTH1 pathway, thereby affecting intracellular Fe2+ levels. Our results demonstrate that NaB treatment (4 mM for 36 h) induced ferroptosis in CRC HCT-116 and Caco-2 cells, as evidenced by inhibited cell proliferation, increased Fe2+ levels, elevated lipid ROS formation, and altered mitochondrial morphology, without affecting normal FHC cells. Specifically, NaB downregulated FTH1 protein levels, increased lysosomal Fe2+, and enhanced NCOA4-FTH1 colocalization in CRC cells. Mechanistically, NaB promoted ferritinophagy through the NCOA4-FTH1 pathway. In a human colorectal cancer xenograft model, NaB inhibited tumor growth, increased intracellular Fe2+ and NCOA4 levels, and decreased FTH1 levels. These findings suggest that NaB promotes ferroptosis in CRC cells by inducing ferritinophagy via the NCOA4-FTH1 pathway, highlighting its potential as an anticancer agent against CRC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nutrition and Food Hygiene, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou 510515, Guangdong, China.
- Department of Nutrition and Food Hygiene, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou 510515, Guangdong, China. Electronic address: s…
Zitieren
APA
Liu, L., Liu, Y., Zhou, X., He, H., Chen, N., Qin, Y., Sun, X., Bian, Z., Zhang, Q., Mao, L., & Sun, S. (2025). Sodium butyrate induces ferroptosis in colorectal cancer cells by promoting NCOA4-FTH1-mediated ferritinophagy. International Immunopharmacology, 163, 115188. https://doi.org/10.1016/j.intimp.2025.115188
Vancouver
Liu L, Liu Y, Zhou X, He H, Chen N, Qin Y, et al. Sodium butyrate induces ferroptosis in colorectal cancer cells by promoting NCOA4-FTH1-mediated ferritinophagy. International Immunopharmacology. 2025;163:115188. doi:10.1016/j.intimp.2025.115188
BibTeX
@article{Liu2025,
author = {Liu, Lulin and Liu, Yingyin and Zhou, Xin and He, Huaxing and Chen, Nachuan and Qin, Yong and Sun, Xiaodie and Bian, Zhongbo and Zhang, Qiuyu and Mao, Lianzhi and Sun, Suxia},
title = {Sodium butyrate induces ferroptosis in colorectal cancer cells by promoting NCOA4-FTH1-mediated ferritinophagy},
journal = {International Immunopharmacology},
year = {2025},
volume = {163},
pages = {115188},
doi = {10.1016/j.intimp.2025.115188}
}
EUVIMED